ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 109 filers reported holding ENZO BIOCHEM INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $874,000 | -9.2% | 320,061 | -7.6% | 0.00% | 0.0% |
Q4 2018 | $963,000 | -74.1% | 346,411 | -61.5% | 0.00% | 0.0% |
Q3 2018 | $3,712,000 | +51.3% | 900,732 | +90.6% | 0.00% | -50.0% |
Q2 2018 | $2,453,000 | -33.8% | 472,675 | -30.1% | 0.00% | -33.3% |
Q1 2018 | $3,707,000 | -30.2% | 676,437 | +3.8% | 0.00% | -25.0% |
Q4 2017 | $5,313,000 | -31.0% | 651,928 | -11.4% | 0.00% | -20.0% |
Q3 2017 | $7,701,000 | +30.6% | 735,555 | +37.8% | 0.01% | +25.0% |
Q2 2017 | $5,895,000 | +89.8% | 533,923 | +43.9% | 0.00% | +100.0% |
Q1 2017 | $3,106,000 | +42.2% | 371,069 | +17.9% | 0.00% | 0.0% |
Q4 2016 | $2,184,000 | +39.8% | 314,768 | +2.6% | 0.00% | +100.0% |
Q3 2016 | $1,562,000 | +31.6% | 306,823 | +54.3% | 0.00% | 0.0% |
Q2 2016 | $1,187,000 | +331.6% | 198,868 | +129.6% | 0.00% | – |
Q3 2015 | $275,000 | -46.9% | 86,606 | -49.4% | 0.00% | – |
Q2 2015 | $518,000 | -10.8% | 171,052 | -13.1% | 0.00% | – |
Q1 2015 | $581,000 | -28.8% | 196,878 | +7.2% | 0.00% | -100.0% |
Q4 2014 | $816,000 | -19.8% | 183,711 | -7.0% | 0.00% | 0.0% |
Q3 2014 | $1,018,000 | +9.2% | 197,624 | +11.3% | 0.00% | 0.0% |
Q2 2014 | $932,000 | – | 177,524 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
Fondren Management LP | 175,863 | $593,000 | 0.56% |
MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
Leap Investments LP | 11,811 | $40,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |